Dr Srijit Seal
Dr Srijit Seal is Principal Scientist at Human Chemical Company and Visiting Researcher at Uppsala University. His research focuses on chemoinformatics and computational biology, particularly the application of machine learning and Cell Painting to investigate small-molecule bioactivity, image-based profiling and drug discovery.
Previously, he was Senior Scientist at Merck US and completed his postdoctoral research at the Broad Institute of MIT and Harvard, under the supervision of Anne Carpenter and Shantanu Singh.
He obtained his PhD from the University of Cambridge under the supervision of Andreas Bender. He also serves on the Board of Directors of the American Society for Cellular and Computational Toxicology and on the Editorial Board of the Journal of Cheminformatics.
Contact info
- Website:
- https://srijitseal.com/
ArticleScientists are already using AI agents. Most of what they learn goes unpublished.
Dr Raminderpal Singh speaks to Dr Srijit Seal about how AI agents are changing computational drug discovery, the impact on scientists’ daily work and why valuable findings remain unpublished.